Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial S Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum, F Saleem, ... EClinicalMedicine 36, 2021 | 57 | 2021 |
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma S Ali, SM Uddin, A Ali, F Anjum, R Ali, E Shalim, M Khan, I Ahmed, ... Immunotherapy 13 (5), 397-407, 2021 | 32 | 2021 |
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a … S Ali, S Luxmi, F Anjum, SM Muhaymin, SM Uddin, A Ali, MR Ali, ... Trials 21, 1-3, 2020 | 15 | 2020 |
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine. 2021; 36: 100926 S Ali, SM Uddin, E Shalim | 5 | 2021 |
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial S Ali, E Shalim, F Farhan, F Anjum, A Ali, SM Uddin, F Shahab, M Haider, ... Trials 23 (1), 932, 2022 | 1 | 2022 |
Relationship of Blood Group Type and SARS-CoV-2 Infection: Experience in A Peripheral Military Hospital. MS Badsha, MMR Khan, SMB Uddin, K Nesa Journal of Bangladesh College of Physicians & Surgeons 39 (2), 2021 | 1 | 2021 |
Macromolecular characterization and growth kinetics of Arthrospira platensis and Chlorella Vulgaris as affected by different media (synthetic and Anaerobic Digestor Effluent)-A … A Abid, H Khan, TF Zeb, SM Uddin, R Amin, S Khan, S Ali | | 2020 |
FORMULATION OF A COST-EFFECTIVE MEDIUM TO SUPPORT HIGH BIOMASS PRODUCTION AND IMPROVED AMINO ACID PROFILE OF ARTHROSPIRA PLATENSIS S Ali Pakistan Journal of Science 72 (4), 2020 | | 2020 |